by Sanius | Sep 28, 2022 | Industry Insights, scdmonth
What does the data tell us about health inequality for Sickle Cell Disease in the UK? / The clinical and patient perspective. There were over 150,000 avoidable patient deaths across the UK in 2020, a significant spike from previous years. Many of these patients came...
by Sanius | Sep 26, 2022 | test
We are excited to be a key strategic partner on supporting innovative therapies for patients living with sickle cell. About Sanius HealthSanius Health is a London based, patient-owned company which focuses primarily on patients living with Sickle Cell Disease and...
by Sanius | Sep 26, 2022 | Disease management, Industry Insights, scdmonth
Sickle Cell Disease: Clinician Dr. Sanne Lugthart Speaks on Need to Accelerate Better SCD Care Dr. Sanne Lugthart is more than a clinician to the people she treats. For the Sickle Cell Disease (SCD) patients she treats at University Hospitals of Bristol, many of...
by Sanius | Sep 23, 2022 | Disease management, Industry Insights, scdmonth
Dr Gareth Goodier Joins Sanius Health During Sickle Cell Awareness Month, in Bid to Accelerate Global SCD Clinical Research Patient platform, research and human health data Company Sanius Health announced today the appointment of Dr Gareth Goodier as sector strategic...
by Sanius | Sep 22, 2022 | Disease management, Industry Insights, scdmonth
This is What Sickle Cell Disease Looks Like: A Million Different Stories, All Beginning with the Same question – how do we change this? Good health is determined by how optimally a person’s social, environmental and economic conditions impact their lives. Their...
Recent Comments